Premium
Distribution and function of FSH receptor genetic variants in normal men
Author(s) -
Asatiani K.,
Gromoll J.,
Eckardstein S. V.,
Zitzmann M.,
Nieschlag E.,
Simoni M.
Publication year - 2002
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1046/j.1439-0272.2002.00493.x
Subject(s) - follicle stimulating hormone receptor , genotype , sertoli cell , biology , endocrinology , spermatogenesis , medicine , receptor , follicle stimulating hormone , gene isoform , basal (medicine) , andrology , hormone , luteinizing hormone , genetics , gene , insulin
Summary. Follicle stimulating hormone (FSH) plays a key role in the maintenance of qualitatively and quantitatively normal spermatogenesis. It controls gamete development through Sertoli cells, via binding to its receptor. The influence and importance of FSH receptor (FSHR) variants on Sertoli cell function is not completely understood and remains to be investigated. In this retrospective study, we explored the impact and action of two distinct FSHR isoforms, Thr307/Asn680 and Ala307/Ser680, in a large group of men. This investigation includes 288 normal healthy men, 86 of whom were proven fathers previously studied, and 202 were newly recruited subjects. The FSHR polymorphism at position 680 was analyzed in the whole group, while position 307 was investigated in 150 subjects, both of them by single‐stranded conformation polymorphism (SSCP) gel electrophoresis. The distribution frequency for position 680 was 29% for the Asn/Asn, 52% for the Asn‐Ser, 19% for the Ser‐Ser variant, and for position 307, 27% for the Thr‐Thr, 55% for the Ala‐Thr, 18% for the Ala‐Ala, respectively. Polymorphism combinations that were different from Thr307/Asn680 – Ala307/Ser680 were found in four subjects. When subjects were grouped according to genotype at position 680, no significant differences between basal FSH, testosterone, inhibin B levels and semen parameters were found. This clinical finding demonstrates that, differently from females, in whom a significant correlation between FSHR polymorphism and basal FSH levels was found, the FSHR genotype has no influence on clinical parameters in males.